NASDAQ: TSHA
Taysha Gene Therapies Inc Stock Ownership - Who owns Taysha Gene Therapies?

Insider buying vs selling

Have Taysha Gene Therapies Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul B. Manning10% Owner2024-06-271,333,333$2.25
$3.00MBuy

1 of 1

TSHA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TSHA insiders and whales buy or sell their stock.

TSHA Shareholders

What type of owners hold Taysha Gene Therapies Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC9.11%18,678,527$31.01MInstitution
Avoro Capital Advisors LLC9.10%18,650,000$30.96MInstitution
Rtw Investments LP7.29%14,946,420$24.81MInstitution
Blackrock Inc 16.60%13,520,533$22.44MInstitution
Blackrock Inc6.60%13,520,533$22.44MInstitution
Ra Capital Management LP5.31%10,872,503$18.05MInstitution
Ra Session Ii4.40%9,012,837$14.96MInsider
Vr Adviser LLC4.39%9,000,000$14.94MInstitution
Vanguard Group Inc4.03%8,265,459$13.72MInstitution
Morgan Stanley3.74%7,663,993$12.72MInstitution

1 of 3

TSHA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TSHA76.56%15.29%Net Buying
ALDX61.63%33.79%Net Buying
CDXS46.66%53.34%Net BuyingNet Buying
ATAI6.90%37.44%Net Selling
TRML54.93%45.07%Net Buying

Taysha Gene Therapies Stock Ownership FAQ

Who owns Taysha Gene Therapies?

Taysha Gene Therapies (NASDAQ: TSHA) is owned by 76.56% institutional shareholders, 15.29% Taysha Gene Therapies insiders, and 8.15% retail investors. Ra Session Ii is the largest individual Taysha Gene Therapies shareholder, owning 9.01M shares representing 4.40% of the company. Ra Session Ii's Taysha Gene Therapies shares are currently valued at $15.77M.

If you're new to stock investing, here's how to buy Taysha Gene Therapies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.